This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
RELIEVE-HF failed to meet its primary efficacy endpoint and did not reduce heart failure events or improve quality of life in heart failure patients with a preserved ejection fraction (HFpEF). For more information: www.corviamedical.com If you enjoy this content, please share it with a colleague
ii The DEFINE AFib clinical study enrolled 973 patients using an app-based enrollment feature and characterized the impact of AF burden on patient outcomes and quality of life. By 2030, approximately 12.2 million people in the U.S. will have AF, an irregular and potentially dangerous heart rhythm. 2024, May 15).
Cardiac rhythm management devices including pacemakers (PM) and implantable cardioverter defibrillators (ICD) can be life-saving and improve quality of life. However, PM and ICD lead malfunction and failure can occur and when severe enough result in recall.
This study aimed to evaluate the impact of higher backup pacing rates in HFpEF patients with preexisting pacemaker systems that limit pacemaker-mediated dyssynchrony across left ventricular (LV) volumes and ejection fraction (LVEF). No evidence of heterogeneity was found across LV volumes or LVEF for pacemaker-detected AF burden.
Sick sinus syndrome (SSS) is a common condition resulting in reduced quality of life, syncope, and pacemaker (PPM) implantation, but predictors have not been elucidated.
Sick sinus syndrome (SSS) is a common condition resulting in reduced quality of life, syncope, and pacemaker (PPM) implantation, but predictors have not been elucidated.
Guidelines recommend permanent pacemaker (PPM) implantation in patients with sinus node dysfunction (SND) to improve quality of life. Patients with heart failure with preserved ejection fraction (HFpEF) have many comorbidities including SND, but the optimal treatment approach for HFpEF with SND is uncertain.
Cardioneuroablation could be a reasonable alternative to pacemaker implantation in symptomatic carotid sinus syndrome. CSS, carotid sinus syndrome; CSM, carotid sinus massage; HR, heart rate; SF-36 QLQ, SF-36 quality-of-life questionnaire. Cardioneuroablation for the management of carotid sinus syndrome. male, mean age 63.812.3
Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. In addition, the group with the BiV pacemaker were less likely to be hospitalized for heart failure flare-ups.
Green: Micra leadless pacemaker; blue: WiSE-CRT system LV endocardial electrode; and red: WiSE-CRT system subcutaneous battery and ultrasound generator. Carabelli A, Jabeur M, Jacon P, Rinaldi CA, European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. 2021 May 21;23(5):740-747.
These changes were paralleled by improvements in heart failure‐related quality of life (myPACE Minnesota Living with Heart Failure Questionnaire improved by 16.1 BackgroundHeart failure with preserved ejection fraction ≥50% is prevalent with few evidence‐based therapies. versus usual care 1.2 [0.2],P=0.008) versus usual care 6.8 [3.1],P=0.038)
We speculate that, if added to pacemakers, this cardio-locomotor coupling technology may maximize CRT efficiency and increase exercise participation and quality of life in patients with CHF. Mean arterial pressure was significantly lower during diastolic walking (85±12 versus 98±20 mm Hg;P=0.007).CONCLUSIONS:In
“The recovery of arm and hand function after a stroke often stalls or even declines, leaving many patients with chronic motor deficits that limit their independence and quality of life. New treatments that can boost the benefits of physical rehabilitation are desperately needed,” said the study’s lead author Teresa J.
By detecting and addressing heart problems early, you can reduce your risk of serious complications and improve your quality of life. At AMS Cardiology, we are dedicated to providing the highest quality care for our patients. Regular check-ups are essential for maintaining optimal heart health.
Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs. Overcoming status quo bias and embracing the latest evidence-based practices are essential steps toward delivering high-quality, personalized care in cardiometabolic medicine.
Patients with more severe obesity were more likely to have responder characteristics for atrial shunt therapy (fewer pacemakers and lower exercise pulmonary vascular resistance [PVR]). Echocardiography demonstrated increased CO with obesity, but not estimated right atrial (RA) pressure or E/e′. Overall, 60.9% of patients had BMI ≥30 kg/m 2.
Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. Medications that improve quality of life in heart failure for example include diuretics.
Implantable Devices Implantable cardiac devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), are crucial in managing arrhythmias and other cardiac conditions. It ultimately aims to improve outcomes and enhance the quality of life for individuals with heart-related conditions.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content